211At labeled substance P (5-11) as potential radiopharmaceutical for glioma treatment.
Lyczko M, Pruszynski M, Majkowska-Pilip A, Lyczko K, Was B, Meczynska-Wielgosz S, Kruszewski M, Szkliniarz K, Jastrzebski J, Stolarz A, Bilewicz A.
Lyczko M, et al. Among authors: pruszynski m.
Nucl Med Biol. 2017 Oct;53:1-8. doi: 10.1016/j.nucmedbio.2017.05.008. Epub 2017 May 25.
Nucl Med Biol. 2017.
PMID: 28683361